Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Prostate Cancer Disappointment Means Lilly Might Finally Get The Point

Dec 19 2023

• By Elizabeth Cairns

Unhappy and disappointed customer giving low rating and negative feedback in survey, poll or questionnaire. Sad and dissatisfied man giving review about service quality. Bad user experience. - Image

Related Content

Lilly Looks To Take POINT On Emerging Cancer Radiopharmaceutical Space

Oct 03 2023

ESMO 23: Pluvicto Fulfils Promise For Prostate Cancer Label Expansion

Oct 18 2023

Related Companies

Eli Lilly and Company

POINT Biopharma Global Inc.

Johnson & Johnson

Pfizer Inc.

Astellas Pharma, Inc.

Novartis AG

Additional Topics

Clinical Trials Companies Commercial Deals Research & Development Cancer Oncology BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window